Telaprevir for Retreatment of HCV Infection von ZEUZEM, Stefan, ANDREONE, Pietro, FERENCI, Peter, NEVENS, Frederik, MÜLLHAUPT, Beat, POCKROS, Paul, TERG, Ruben, SHOUVAL, Daniel, VAN HOEK, Bart, WEILAND, Ola, VAN HEESWIJK, Rolf, DE MEYER, Sandra, POL, Stanislas, LUO, Don, BOOGAERTS, Griet, POLO, Ramon, PICCHIO, Gaston, BEUMONT, Maria, LAWITZ, Eric, DIAGO, Moises, ROBERTS, Stuart, FOCACCIA, Roberto, YOUNOSSI, Zobair, FOSTER, Graham R, HORBAN, Andrzej

Volltext

Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment von Bartels, Doug J, Sullivan, James C, Zhang, Eileen Z, Tigges, Ann M, Dorrian, Jennifer L, De Meyer, Sandra, Takemoto, Darin, Dondero, Elizabeth, Kwong, Ann D, Picchio, Gaston, Kieffer, Tara L

Volltext

Lack of antiviral activity of darunavir against SARS-CoV-2 von De Meyer, Sandra, Bojkova, Denisa, Cinatl, Jindrich, Van Damme, Ellen, Buyck, Christophe, Van Loock, Marnix, Woodfall, Brian, Ciesek, Sandra

Volltext

Efficacy of Once-Daily Darunavir/Ritonavir 800/100 mg in HIV-Infected, Treatment-Experienced Patients With No Baseline Resistance-Associated Mutations to Darunavir von De Meyer, Sandra M J, Spinosa-Guzman, Sabrina, Vangeneugden, Tony J, de Béthune, Marie-Pierre, Miralles, G Diego

Volltext

Telaprevir for Retreatment of HCV Infection von Zeuzem, Stefan, Andreone, Pietro, Pol, Stanislas, Lawitz, Eric, Diago, Moises, Roberts, Stuart, Focaccia, Roberto, Younossi, Zobair, Foster, Graham R, Horban, Andrzej, Ferenci, Peter, Nevens, Frederik, Müllhaupt, Beat, Pockros, Paul, Terg, Ruben, Shouval, Daniel, van Hoek, Bart, Weiland, Ola, Van Heeswijk, Rolf, De Meyer, Sandra, Luo, Don, Boogaerts, Griet, Polo, Ramon, Picchio, Gaston, Beumont, Maria

Volltext

In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants von Verbinnen, Thierry, Fevery, Bart, Vijgen, Leen, Jacobs, Tom, De Meyer, Sandra, Lenz, Oliver

Volltext

Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48 von ORTIZ, Roberto, DEJESUS, Edwin, VANGENEUGDEN, Tony, SPINOSA-GUZMAN, Sabrina, KHANLOU, Homayoon, VORONIN, Evgeniy, VAN LUNZEN, Jan, ANDRADE-VILLANUEVA, Jaime, FOURIE, Jan, DE MEYER, Sandra, DE PAUW, Martine, LEFEBVRE, Eric

Volltext

Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region von Sarrazin, Christoph, Lathouwers, Erkki, Peeters, Monika, Daems, Bjorn, Buelens, Annemie, Witek, James, Wyckmans, Yves, Fevery, Bart, Verbinnen, Thierry, Ghys, Anne, Schlag, Michael, Baldini, Alessandra, De Meyer, Sandra, Lenz, Oliver

Volltext

Pharmacodynamic, prognostic, and predictive biomarkers in severe and critical COVID-19 patients treated with sirukumab von Thys, Kim, Loza, Matthew J., Lynn, Linghua, Callewaert, Katleen, Varma, Lisa, Crabbe, Marjolein, Van Wesenbeeck, Liesbeth, Van Landuyt, Erika, De Meyer, Sandra, Aerssens, Jeroen, Verbrugge, Inge

Volltext

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials von Sullivan, James C., De Meyer, Sandra, Bartels, Doug J., Dierynck, Inge, Zhang, Eileen Z., Spanks, Joan, Tigges, Ann M., Ghys, Anne, Dorrian, Jennifer, Adda, Nathalie, Martin, Emily C., Beumont, Maria, Jacobson, Ira M., Sherman, Kenneth E., Zeuzem, Stefan, Picchio, Gaston, Kieffer, Tara L.

Volltext

TMC114, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor Active against Protease Inhibitor-Resistant Viruses, Including a Broad Range of Clinical Isolates von DE MEYER, Sandra, AZIJN, Hilde, SURLERAUX, Dominique, JOCHMANS, Dirk, TAHRI, Abdellah, PAUWELS, Rudi, WIGERINCK, Piet, DE BETHUNE, Marie-Pierre

Volltext

An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay von Sarrazin, Christoph, Dierynck, Inge, Cloherty, Gavin, Ghys, Anne, Janssen, Katrien, Luo, Donghan, Witek, James, Buti, Maria, Picchio, Gaston, De Meyer, Sandra

Volltext

Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials von Kieffer, Tara L, De Meyer, Sandra, Bartels, Doug J, Sullivan, James C, Zhang, Eileen Z, Tigges, Ann, Dierynck, Inge, Spanks, Joan, Dorrian, Jennifer, Jiang, Min, Adiwijaya, Bambang, Ghys, Anne, Beumont, Maria, Kauffman, Robert S, Adda, Nathalie, Jacobson, Ira M, Sherman, Kenneth E, Zeuzem, Stefan, Kwong, Ann D, Picchio, Gaston

Volltext

Resistance Profile of Darunavir : Combined 24-Week Results from the POWER Trials von DE MEYER, Sandra, VANGENEUGDEN, Tony, VAN BAELEN, Ben, DE PAEPE, Els, VAN MARCK, Herwig, PICCHIO, Gaston, LEFEBVRE, Eric, DE BETHUNE, Marie-Pierre

Volltext

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir von Susser, Simone, Flinders, Mathieu, Reesink, Henk W, Zeuzem, Stefan, Lawyer, Glenn, Ghys, Anne, Van Eygen, Veerle, Witek, James, De Meyer, Sandra, Sarrazin, Christoph

Volltext

Safety and Efficacy of Darunavir (TMC114) With Low-Dose Ritonavir in Treatment-Experienced Patients: 24-Week Results of POWER 3 von Molina, Jean-Michel, Cohen, Calvin, Katlama, Christine, Grinsztejn, Beatriz, Timerman, Artur, Pedro, Rogério de Jesus, Vangeneugden, Tony, Miralles, Diego, Meyer, Sandra De, Parys, Wim, Lefebvre, Eric

Volltext

Discovery and Selection of TMC114, a Next Generation HIV-1 Protease Inhibitor von Surleraux, Dominique L. N. G, Tahri, Abdellah, Verschueren, Wim G, Pille, Geert M. E, de Kock, Herman A, Jonckers, Tim H. M, Peeters, Anik, De Meyer, Sandra, Azijn, Hilde, Pauwels, Rudi, de Bethune, Marie-Pierre, King, Nancy M, Prabu-Jeyabalan, Moses, Schiffer, Celia A, Wigerinck, Piet B. T. P

Volltext

Deep-Sequencing Analysis of the Gene Encoding the Hepatitis C Virus Nonstructural 3-4A Protease Confirms a Low Prevalence of Telaprevir-Resistant Variants at Baseline and the End o... von Dierynck, Inge, Thys, Kim, Ghys, Anne, Sullivan, James C., Kieffer, Tara L., Aerssens, Jeroen, Picchio, Gaston, De Meyer, Sandra

Volltext

Assessment of etravirine resistance in HIV-1-infected paediatric patients using population and deep sequencing: final results of the PIANO study von Tambuyzer, Lotke, Thys, Kim, Hoogstoel, Annemie, Nijs, Steven, Tomaka, Frank, Opsomer, Magda, De Meyer, Sandra, Vingerhoets, Johan

Volltext

Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE von Van Eygen, Veerle, Thys, Kim, Van Hove, Carl, Rimsky, Laurence T., De Meyer, Sandra, Aerssens, Jeroen, Picchio, Gaston, Vingerhoets, Johan

Volltext